1. Home
  2. CRON vs CAC Comparison

CRON vs CAC Comparison

Compare CRON & CAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRON
  • CAC
  • Stock Information
  • Founded
  • CRON N/A
  • CAC 1875
  • Country
  • CRON Canada
  • CAC United States
  • Employees
  • CRON N/A
  • CAC N/A
  • Industry
  • CRON Medicinal Chemicals and Botanical Products
  • CAC Major Banks
  • Sector
  • CRON Health Care
  • CAC Finance
  • Exchange
  • CRON Nasdaq
  • CAC Nasdaq
  • Market Cap
  • CRON 809.4M
  • CAC 688.3M
  • IPO Year
  • CRON N/A
  • CAC 1997
  • Fundamental
  • Price
  • CRON $2.69
  • CAC $41.20
  • Analyst Decision
  • CRON
  • CAC Buy
  • Analyst Count
  • CRON 0
  • CAC 3
  • Target Price
  • CRON N/A
  • CAC $48.00
  • AVG Volume (30 Days)
  • CRON 2.8M
  • CAC 56.5K
  • Earning Date
  • CRON 11-11-2025
  • CAC 10-28-2025
  • Dividend Yield
  • CRON N/A
  • CAC 4.22%
  • EPS Growth
  • CRON N/A
  • CAC 4.80
  • EPS
  • CRON 0.05
  • CAC 3.11
  • Revenue
  • CRON $130,282,000.00
  • CAC $197,501,000.00
  • Revenue This Year
  • CRON $19.67
  • CAC $42.11
  • Revenue Next Year
  • CRON $30.56
  • CAC $5.51
  • P/E Ratio
  • CRON $53.27
  • CAC $12.78
  • Revenue Growth
  • CRON 28.01
  • CAC 21.74
  • 52 Week Low
  • CRON $1.60
  • CAC $34.53
  • 52 Week High
  • CRON $2.77
  • CAC $50.07
  • Technical
  • Relative Strength Index (RSI)
  • CRON 64.73
  • CAC 59.03
  • Support Level
  • CRON $2.50
  • CAC $39.50
  • Resistance Level
  • CRON $2.63
  • CAC $40.75
  • Average True Range (ATR)
  • CRON 0.09
  • CAC 0.88
  • MACD
  • CRON -0.00
  • CAC -0.01
  • Stochastic Oscillator
  • CRON 90.00
  • CAC 87.63

About CRON Cronos Group Inc. Common Share

Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.

About CAC Camden National Corporation

Camden National Corporation is a banking solutions provider in the United States. Its core business is providing commercial banking products to individuals and corporates. Its consumer and commercial banking services entail services such as loans and deposits, savings and online banking, treasury management solutions and non-profit products to consumer, institutional, municipal, non-profit and commercial customers. The company also offers investment management and fiduciary services.

Share on Social Networks: